Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis, committed to discovering innovative medicines that treat disease and improve human health.
Disease areas ›
Our longstanding commitment to understanding the underlying molecular basis of disease has enabled us to deepen our knowledge, and turn scientific insights into medical breakthroughs.
Discovery sciences ›
We bring new technologies to bear on understanding the fundamental science behind both normal and disease-related human biology.
Clinical ›
NIBR is unique among pharmaceutical research organizations in the way it incorporates clinical medicine into its early stage “benchtop” drug discovery.
ABOUT NOVARTIS
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis.
